More NewsRead More
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the Seamless Phase 3 Trial of Sapacitabine in AML
October 09, 2014
Cyclacel to Present at BioCentury's Newsmakers in the Biotech Industry Conference
September 19, 2014
Cyclacel's CYC065 CDK Inhibitor Demonstrates Therapeutic Potential in Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements
September 18, 2014
Cyclacel Announces Abstract Selected for Presentation at Society of Hematologic Oncology Annual Meeting
September 10, 2014
Cyclacel Pharmaceuticals to Present at 16th Rodman & Renshaw Annual Global Investment Conference
September 02, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here